glp-1 drugs chemically different clinically similar like Ozempic show promise for more than weight loss. But what's science vs hype? GLP-1-based therapies for type 2

Improves Athletic Performance Intense muscle activity leads to an increase in oxidative molecules, such as reactive oxygen and nitrogen species

VIP peptide has been shown in pharmacological in vitro studies to have a sleep-promoting effect

Individual factorsage, kidney function, concurrent medications, and body compositionaffect how quickly and effectively dose escalation proceeds

Incretin-based therapy of metabolic disease Abstract Incretin-based therapy of metabolic disease Recent studies show that incretin hormone analogues effectively control blood glucose while producing major weight losses and reducing the risk of all-cause mortality, myocardial infarction, stroke and kidney function impairment

Leuk Res 9(10):1283-91, 1985